Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

HTTPS

Secure .gov websites use HTTPS
A lock (LockA locked padlock) or https:// means you have safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Environmental Topics
  • Laws & Regulations
  • Report a Violation
  • About EPA
Contact Us

Grantee Research Project Results

2008 Progress Report: Development of High-Throughput and Real-Time Methods for the Detection of Infective Enteric Viruses

EPA Grant Number: R833008
Title: Development of High-Throughput and Real-Time Methods for the Detection of Infective Enteric Viruses
Investigators: Chen, Wilfred , Yates, Marylynn V. , Myung, Nosang V. , Mulchandani, Ashok
Current Investigators: Chen, Wilfred , Mulchandani, Ashok , Yates, Marylynn V. , Myung, Nosang V.
Institution: University of California - Riverside
EPA Project Officer: Page, Angela
Project Period: August 31, 2006 through August 30, 2009 (Extended to August 26, 2011)
Project Period Covered by this Report: August 31, 2007 through August 30,2008
Project Amount: $600,000
RFA: Development and Evaluation of Innovative Approaches for the Quantitative Assessment of Pathogens in Drinking Water (2005) RFA Text |  Recipients Lists
Research Category: Drinking Water , Water

Objective:

The main goal of this research is to improve on the current analytical methods for quantitative detection of infective enteric viruses, specifically the non-polio enteroviruses (NPEV), in drinking water. The overall objective of the research is to develop methods to provide high-throughput real-time detection and quantitation of infective enteric viruses from contaminated water. The specific objectives of this research are to:

1) Develop a new generation of molecular beacons (MBs) based on quantum dots as the fluorophore and gold nanoparticles as the quencher for improved sensitivity and multiplexing capability

2) Develop a real-time method to probe and quantify infective enteric viruses using TAT- or transferrin-modified nuclease-resistant molecular beacons (MBs) in infected cell lines without permeabilization

3) Develop a genetically engineered cell line to probe and quantify infective enteric viruses by generating a protease-sensitive FRET protein pair using an improved CFP-YFP pair

4) Evaluate the use of flow cytometry for high-throughput sample processing

 5) Evaluate the above methods to rapidly detect and quantify the presence of infective NPEV in environmental water samples.

Progress Summary:

A simple, flow cytometry-based assay for detecting poliovirus infection using mammalian cells expressing CFP-YFP protein pair undergoing Fluorescence Resonance Energy Transfer (FRET)
 
Experiments were conducted to evaluate if FACS was a sensitive method for detecting PV1 infection and to determine if fluorescence activated cell sorting  (FACS) assay was able to detect quantitative differences in the number of infected cells in the sample using the FRET-based cellular reporter system for PV 2Apro activity. BGM-PV cells were infected with ten-fold serial dilutions of PV1, with the lowest dilution having a multiplicity of infection ( MOI) of 0.6. Quantification of infected cells was accomplished by FACS. Cells were gated based on size and granularity to include only intact cells. Figure 1 shows representative data plots generated from FACS analysis. After 12 hpi, 78% of the cells (counted from 30,000 events) (Fig. 1A) showed a decrease in yellow fluorescent protein (YFP) intensity (indicating disruption of FRET), compared with the uninfected cells with less than 0.2% of the population were positive (Fig 1F). Also, the numbers of infected cells decreased as the infective viruses used to infect the cells become more diluted (Fig. 1B to Fig. 1E), suggesting that there is a clear correlation between the concentration of the infective virus dose and the number of infected cells. This further suggests that FACS can distinguish infected cells from non-infected cells based on the change in CFP/YFP intensity brought about by disruption of FRET resulting from viral protease activity.
 
Next, we determined the time course of PV1 infection, to identify the optimum incubation time for virus detection. BGM-PV cells were infected with PV1 at an MOI of 0.2, and cells were collected at 0, 2, 5, 8, 12, 16, and 24 h post infection (hpi). Infected cells were detected as early as 5 hpi (3% positives) and continued to increase until 8 hpi (4% positives). A second round of infection was observed between 8 and 12 hpi, and the number of infected cells continued to increase over time (Fig. 2). This result demonstrated that PV 2Apro activity was produced and active as early as 5 hpi. Progeny virions on the other hand were first released around 8 hpi, and that these particles initiated the second round of infection. Increasing numbers of infected cells were detected as the infection progressed indicating that the FACS assay was suitable for following the kinetics of infection.
 
 
 
Fig. 1. Poliovirus 1 (PV1) infection of BGMPV cells. Confluent monolayers of BGMPV in 6-well plates were infected with ten-fold dilutions of PV1. After 12 h post infection (hpi), cells were trypsinized, washed with 19% FBS followed by 1X TBSS + 3 mM EDTA (pH 8.0), resuspended in the later, and then subjected to FACS. x axis, CFP intensity; y axis, YFP intensity from CFP excitation. The percentage of infected cells shown as % above each graph was determined by counting the number of cells without FRET signal divided by the total number of cells counted. A-E, 10-1 to 10-5 dilutions; F, uninfected cells.
Fig. 2. Time course of PV1 infection of BGMPV at a Multiplicity of Infection (MOI) of 0.2 as determined by using FACS. Cells were grown and infected as described, and were harvested at different time points. Those cells that lose FRET due to the uncoupling of CFP-YFP fluorescent pairs brought about by PV1 infection were counted using FACS.
 
To determine the sensitivity of the FACS-based assay at the shortest time possible, we directly compared the FACS-based and plaque assays for the same dilution or preparation of PV1. After 12 hpi, cells were harvested and subjected to FACS analysis. A linear relationship (R2 = 0.98) was observed between FACS-based assay and plaque assay results, indicating that the two assays were similar measures of infectious virus in the sample (Fig. 3).
 

Fig. 3. Direct comparison of FACS and plaque assays. Confluent monolayer of BGMPV in 12-well plates were infected with PV1 (20 min absorption). For FACS assay, cells were harvested after 12 h as described, and then subjected to FACS. For plaque assay, infected cells were overlaid with 1% CMC in MEM (+ 2% FBS), incubated for 48 h, then fixed/stained with 1% crystal violet in 3.7% formaldehyde solution.

 

In this study, we describe the use of nuclease-resistant molecular beacons (MBs) for the real-time detection of coxsackievirus B6 (CVB6) replication in living Buffalo green monkey kidney (BGMK) cells via TAT peptide delivery. A nuclease-resistant MB containing 2'-O-methyl RNA bases with phosphorothioate internucleotide linkages was designed to specifically target an 18-bp 5' noncoding region of the viral genome. For intracellular delivery, a cell-penetrating TAT peptide was conjugated to the MB using a thiol-maleimide linkage (Fig. 4A). As expected, the modified MBs were highly resistant to nuclease cleavage by DNAase I (Fig. 4B). In contrast, an unmodified MB was susceptible to nuclease degradation, resulting in almost instantaneous increase in fluorescence. The dual modifications had no effect on the hybridization kinetics of the MB, as a rapid increase in fluorescence was observed in the presence of a complimentary target (Fig. 4C).

Fig. 4. (A) A schematic representation of the TAT-modified nuclease-resistant MB. (B) Nuclease sensitivity assays utilizing ribonuclease-free DNase I. The fluorescence of the nuclease-resistant MB is shown in yellow and the fluorescence of an un-modified MB is shown in red. The background fluorescent signals (shown in black and green) without DNase I addition are also shown. (C) Kinetics of hybridization of TAT-modified MBs CVB6 with (green) or without (orange) complementary oligos.

 

The intracellular delivery efficiency was tested by incubating 0.5, 1, or 2 μM of MB-target hybrids with a monolayer of Buffalo green monkey kidney (BGMK) cells. Fluorescence was detectable in 100% of the living cells as early as 15 min after introduction of the MB-target hybrids (Fig. 5A). The time-lapse images showed that the degree of cellular uptake increased after 15 min and reached saturation after 1 h incubation. The fluorescence intensity was constant for up to 12 h, indicating that the MB-target hybrids were retained inside the cells after delivery and remained resistant to the intracellular RNase H. Unhybridized MB was also introduced into BGMK cells and no fluorescence was detected during the same 12 h period, again indicating the intracellular resistance of the modified MBs to nuclease attack (Fig. 5B).  In contrast, in the absence of TAT, no internalization of MBs was observed and fluorescence was detected only in the medium (Fig. 5B), confirming the effectiveness of the TAT peptide for rapid intracellular delivery

 

Fig. 5. Intracellular delivery of (A) MB CBV6-TAT/target hybrids or (B) MB without TAT modification or without targets. BGMK cells were incubated with 1 µM MB for 12 h, and images were captured using a fluorescent microscope. Scale bar, 20 µm.

After validating the properties of TAT-modified MBs, their ability to detect viral RNA was tested. A confluent monolayer of BGMK cells was first incubated with 1 μM MB for 30 min before being infected with 10-fold serial dilutions of CVB6, followed by fluorescence microscopy. Compared with uninfected cultures (0 PFU), where no fluorescent cells were present independent of time, a greater number of fluorescent cells was detected at 2 h post infection (p.i.) for the culture infected with a viral dosage corresponding to one plaque-forming unit (PFU) (Fig. 6A). The higher number of fluorescent cells compared to PFU is likely due to the fact that not all viruses that infect a cell are necessarily able to complete the replication cycle.  This result is also consistent with the higher infectious virus titers observed using the quantal assay, which is based on the direct microscopic viewing of cells for virus-induced cytopathic effects, than the plaque assay. This 2-h detection window is substantially faster than a similar approach reported using cell fixation/permeabilization. It is possible that the rapid and non-invasive intracellular delivery enables hybridization with viral RNA to occur shortly after virus uncoating without the possibility of degradation caused by fixation/permeabilization. To our knowledge, detection of 1 PFU of CVB6, or any other enterovirus, at 2 hpi has never been reported.
 
Using the 2-h infection window, the utility of TAT-modified MBs to quantify infectious CVB6 dosages was tested.  Cells were infected with 1 to 200 PFU CVB6 per well and the average number of fluorescent cells was recorded. A linear correlation was obtained by plotting the number of fluorescent cells versus PFU (Fig. 6B). The number of PFU can be easily determined using the correlation obtained after direct counting of fluorescent cells. More importantly, the method can be used to provide rapid quantification of infectious CVB6 dosages within 2 h p.i. compared to the minimum 48-h incubation period for the plaque assay.

Fig. 6. (A) Visualization of BGMK cells infected with 0, 1 or 105 PFU at 2 hpi (B) The correlation between the number of PFU and fluorescent cells at 2 hpi Error bars represent the standard deviation of three replicate experiments.

 

The ability to detect infected cells continuously should allow one to follow the spreading of infectious viruses on a real-time basis. To determine whether this was, indeed, possible, BGMK cells were infected at a very low infection dosage (MOI: 0.01 pfu/cell) and monitored continuously using a fluorescence microscope in a fixed area for 12 h. Fig. 7 shows the cell to cell progression of virus spreading at 6 representative time points. Several infected cells were observed at 15 min p.i., suggesting that the viruses entered the cells and started the uncoating process within 15 min. The number of fluorescent cells slowly increased with time suggesting continuous virus infection. By 6 h p.i., a further outward spread of fluorescent cells was observed, indicating the secondary spreading of infection from progeny virions to cells surrounding the initial infected cells. The number of fluorescent cells continued to increase with time and finally spread outward to the entire observation area by 12 h p.i. The majority of infected cells remained adherent and some fluorescence was visible outside the cells, indicating that the fluorescent hybrids with viral RNA entered the extracellular region as a result of the release of progeny virions during cell lysis.

 

Fig. 7. Real-time detection of viral spreading. BGMK cells were first incubated with 1 μM MB, infected with CVB6 at an M.O.I. of 0.01 pfu/cell, and monitored using a fluorescent microscope.

 

Future Activities:

1. In the third year, we will extend our approach by employing quantum dots as the fluorescent donors and gold nanoparticles as quenchers.  In addition, we will also investigate the utility of flow cytometry for the rapid detection using MBs.
 
2. We will construct genetically engineered BGMK cell lines expressing the FRET substrates specific for HAV and investigate their utility for HAV detection.


Journal Articles on this Report : 3 Displayed | Download in RIS Format

Publications Views
Other project views: All 7 publications 7 publications in selected types All 7 journal articles
Publications
Type Citation Project Document Sources
Journal Article Hwang Y-C, Chu JJ-H, Yang PL, Chen W, Yate MV. Rapid identification of inhibitors that interfere with poliovirus replication using a cell-based assay. Antiviral Research 2008;77(3):232-236. R833008 (2008)
R833008 (Final)
  • Abstract from PubMed
  • Full-text: ResearchGate - Abstract & Full Text PDF
    Exit
  • Abstract: ScienceDirect-Abstract
    Exit
  • Journal Article Yeh H-Y, Hwang Y-C, Yates MV, Mulchandani A, Chen W. Detection of Hepatitis A virus using a combined cell culture-molecular beacon assay. Applied and Environmental Microbiology 2008;74(7):2239-2243. R833008 (2008)
    R833008 (Final)
  • Full-text from PubMed
  • Abstract from PubMed
  • Associated PubMed link
  • Full-text: AEM - Full Text HTML
    Exit
  • Abstract: AEM - Abstract
    Exit
  • Other: ResearchGate - Abstract & Full Text PDF
    Exit
  • Journal Article Yeh H-Y, Yates MV, Mulchandani A, Chen W. Visualizing the dynamics of viral replication in living cells via TAt peptide delivery of nuclease-resistant molecular beacons. Proceedings of the National Academy of Sciences of the United States of America 2008;105(45):17522-17525. R833008 (2008)
    R833008 (Final)
  • Full-text from PubMed
  • Abstract from PubMed
  • Associated PubMed link
  • Full-text: PNAS-Full Text HTML
    Exit
  • Abstract: PNAS-Abstract
    Exit
  • Other: PNAS-Full Text PDF
    Exit
  • Supplemental Keywords:

    RFA, Scientific Discipline, PHYSICAL ASPECTS, INTERNATIONAL COOPERATION, Water, POLLUTANTS/TOXICS, Health Risk Assessment, Physical Processes, Microbiology, Microorganisms, Drinking Water, health effects, human health, measurement method, viruses, microbiological organisms, monitoring, pathogens, drinking water contaminants, enteric viruses, exposure, drinking water monitoring, human health effects

    Progress and Final Reports:

    Original Abstract
  • 2007 Progress Report
  • 2009
  • 2010
  • Final Report
  • Top of Page

    The perspectives, information and conclusions conveyed in research project abstracts, progress reports, final reports, journal abstracts and journal publications convey the viewpoints of the principal investigator and may not represent the views and policies of ORD and EPA. Conclusions drawn by the principal investigators have not been reviewed by the Agency.

    Project Research Results

    • Final Report
    • 2010
    • 2009
    • 2007 Progress Report
    • Original Abstract
    7 publications for this project
    7 journal articles for this project

    Site Navigation

    • Grantee Research Project Results Home
    • Grantee Research Project Results Basic Search
    • Grantee Research Project Results Advanced Search
    • Grantee Research Project Results Fielded Search
    • Publication search
    • EPA Regional Search

    Related Information

    • Search Help
    • About our data collection
    • Research Grants
    • P3: Student Design Competition
    • Research Fellowships
    • Small Business Innovation Research (SBIR)
    Contact Us to ask a question, provide feedback, or report a problem.
    Last updated April 28, 2023
    United States Environmental Protection Agency

    Discover.

    • Accessibility
    • Budget & Performance
    • Contracting
    • EPA www Web Snapshot
    • Grants
    • No FEAR Act Data
    • Plain Writing
    • Privacy
    • Privacy and Security Notice

    Connect.

    • Data.gov
    • Inspector General
    • Jobs
    • Newsroom
    • Open Government
    • Regulations.gov
    • Subscribe
    • USA.gov
    • White House

    Ask.

    • Contact EPA
    • EPA Disclaimers
    • Hotlines
    • FOIA Requests
    • Frequent Questions

    Follow.